Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes

Product Description
spectrostar-nano.gif

Experience the future of microplate reader technology today with the SPECTROstar Nano. Using an ultrafast CCD-based spectrometer, it can capture a full UV-Vis absorbance spectrum from 220 to 1000 nm in 1, 2, 5, or 10 nm increments in less than 1 second per well. Monochromators cannot match the speed or resolution of a spectrometer. In addition, it can measure a full spectrum in all microplate formats from 6- to 1536-wells, as well as low volumes (2uL) in BMG LABTECH’s LVis microplate. Full spectra of individual samples can also be assessed by using the integrated cuvette port. This port accommodates standard, micro, and ultra-low volume cuvettes for measurements of 1uL.

The SPECTROstar Nano makes absorbance measurements easy with app-style, one-click button operation and predefined protocols for the most common absorbance assays such as ELISAs, DNA, RNA, protein (Bradford, BCA, Lowry), cell growth, beta-galactosidase, MTT toxicity, enzyme kinetics, and many more.

Some of the outstanding features include:

• Ultra-fast UV/Vis spectrometer
• Spectrum 220 to 1000 nm in <1 sec/well
• Microplate formats up to 1536 wells
• Cuvette port for standard, micro and ultra-low volume cuvettes
• Low volumes down to 2 µL
• Multimode shaking and incubation
• Well scanning, kinetic and endpoint measurements
• Gas vent for atmospheric sensitive samples
• Powerful MARS Data Analysis Software
• Robot compatible
Product SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!